Wuxi Hyatech Co

Wuxi Hyatech Co Equity

The The Equity of Wuxi Hyatech Co (688510.SS) as of Oct 22, 2026 is 1.21 B CNY. In the previous year, The Equity was 1.14 B CNY — a change of 5.78% (higher).

Equity

1.21 BCNY

YoY

5.78%

Last updated:

In 2025, Wuxi Hyatech Co's equity was 1.21 B CNY, a 5.78% increase from the 1.14 B CNY equity in the previous year.

The Wuxi Hyatech Co Equity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity
Date
Equity
Jan 1, 2018
365.15 M CNY
Jan 1, 2019
405.61 M CNY
Jan 1, 2020
939.82 M CNY
Jan 1, 2021
960.63 M CNY
Jan 1, 2022
957.56 M CNY
Jan 1, 2023
1.05 B CNY
Jan 1, 2024
1.14 B CNY
Jan 1, 2025
1.21 B CNY
The Wuxi Hyatech Co Equity history
YEAREquityYoY
1.21 BCNY+5.78%
1.14 BCNY+8.87%
1.05 BCNY+9.54%
957.56 MCNY-0.32%
960.63 MCNY+2.21%
939.82 MCNY+131.71%
405.61 MCNY+11.08%
365.15 MCNY+104.98%
178.14 MCNY+29.50%
137.56 MCNY-11.39%
155.24 MCNY+140.27%
64.61 MCNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Wuxi Hyatech Co Stock analysis

What does Wuxi Hyatech Co do? Wuxi Hyatech Co Ltd generates revenue through the research and development, manufacturing, and sales of key components for aero-engines and medical orthopedic implant forgings. The company produces high-performance components including aviation turbofan engine compressor blades, rotating parts, and structural parts, which are sold domestically and internationally. Its primary customers are aerospace manufacturers and medical device companies requiring specialized forgings for engine parts and orthopedic implants. The firm targets the aerospace and medical sectors with its focus on precision-engineered components for critical applications. The company's product portfolio includes aviation turbofan engine compressor blades, rotating parts, and structural parts, alongside medical orthopedic implant forgings. These products are distributed across domestic and overseas markets, serving both the Chinese aerospace industry and international medical device markets. Wuxi Hyatech's revenue streams are derived from direct sales of these specialized components to industrial and medical clients without third-party intermediaries. Wuxi Hyatech's business model centers on supplying high-precision components for aero-engines and medical orthopedic implants. The company's manufacturing capabilities enable it to produce critical parts for aircraft engines and orthopedic devices, with a focus on domestic and international industrial clients. Revenue is generated through the sale of these specialized forgings to aerospace and medical sectors, leveraging its R&D expertise in component production. Wuxi Hyatech Co is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Wuxi Hyatech Co's Equity

Wuxi Hyatech Co's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Wuxi Hyatech Co's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Wuxi Hyatech Co's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Wuxi Hyatech Co's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Wuxi Hyatech Co’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Wuxi Hyatech Co stock

The Equity of Wuxi Hyatech Co is 1.21 B CNY in 2025.

The Equity of Wuxi Hyatech Co changed from 1.14 B CNY to 1.21 B CNY, representing a 5.78% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of The Equity Wuxi Hyatech Co since 2006 – with annual values, charts, and detailed analysis.

The Equity's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's Wuxi Hyatech Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Wuxi Hyatech Co

All Key Metrics — Wuxi Hyatech Co